Variant report
Variant | esv3322110 |
---|---|
Chromosome Location | chr11:93510554-93512502 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr11:93510592-93510790 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr11:93510432-93510648 | HepG2 | liver: | n/a | chr11:93510490-93510501 |
3 | CEBPB | chr11:93510333-93510621 | K562 | blood: | n/a | chr11:93510490-93510501 |
4 | RCOR1 | chr11:93510695-93510769 | K562 | blood: | n/a | n/a |
5 | USF1 | chr11:93510579-93510911 | K562 | blood: | n/a | n/a |
6 | USF1 | chr11:93510487-93510836 | K562 | blood: | n/a | n/a |
7 | ZNF384 | chr11:93510872-93511035 | K562 | blood: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:93507107..93508647-chr11:93509097..93511898,2 | K562 | blood: | |
2 | chr11:93512153..93515814-chr11:93515942..93518235,3 | K562 | blood: | |
3 | chr11:93459822..93462778-chr11:93509047..93511510,2 | K562 | blood: | |
4 | chr11:93508723..93511571-chr11:93516504..93518182,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MED17 | TF binding region |
ENSG00000166012 | chromatin interactions |
ENSG00000042429 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72976543 | chr11:93510565-93510566 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs371481369 | chr11:93510614-93510615 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs577326497 | chr11:93510628-93510629 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs664647 | chr11:93510634-93510635 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs146273771 | chr11:93510635-93510636 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs200173841 | chr11:93510647-93510648 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs200697487 | chr11:93510648-93510649 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs664619 | chr11:93510656-93510657 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs115718697 | chr11:93510676-93510677 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs66483735 | chr11:93510681-93510682 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs560347369 | chr11:93510694-93510695 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs554827387 | chr11:93510709-93510710 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs12789613 | chr11:93510721-93510722 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs12788872 | chr11:93510722-93510723 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs79201304 | chr11:93510753-93510754 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs539961046 | chr11:93510766-93510767 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs622231 | chr11:93510795-93510796 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs66797025 | chr11:93510804-93510805 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs563247790 | chr11:93510822-93510823 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs550257724 | chr11:93510834-93510835 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs142579817 | chr11:93510844-93510845 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs529980854 | chr11:93510852-93510853 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs622147 | chr11:93510858-93510859 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs645992 | chr11:93510877-93510878 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs146010691 | chr11:93510884-93510885 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs142139812 | chr11:93510918-93510919 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs113646550 | chr11:93510964-93510965 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs577692113 | chr11:93510975-93510976 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs149102102 | chr11:93510989-93510990 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs552713559 | chr11:93511018-93511019 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs570912201 | chr11:93511025-93511026 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs538335951 | chr11:93511026-93511027 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs200537051 | chr11:93511052-93511053 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs545861719 | chr11:93511053-93511054 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs4753103 | chr11:93511119-93511120 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs574759295 | chr11:93511135-93511136 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs4753104 | chr11:93511284-93511285 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs185920086 | chr11:93511291-93511292 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs60567391 | chr11:93511313-93511314 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs58214648 | chr11:93511315-93511316 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs60829358 | chr11:93511317-93511318 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs57614311 | chr11:93511319-93511320 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs60413822 | chr11:93511321-93511322 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs61557506 | chr11:93511323-93511324 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs61090970 | chr11:93511325-93511326 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs545096785 | chr11:93511327-93511328 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs58924527 | chr11:93511329-93511330 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs557373659 | chr11:93511331-93511332 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs376579996 | chr11:93511333-93511334 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs370801705 | chr11:93511335-93511336 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Schizophrenia | 23813976 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93492200-93516600 | Weak transcription | Psoas Muscle | Psoas |
2 | chr11:93492200-93516800 | Weak transcription | Right Ventricle | heart |
3 | chr11:93496000-93513600 | Weak transcription | Brain Inferior Temporal Lobe | brain |
4 | chr11:93498000-93516600 | Weak transcription | Brain Hippocampus Middle | brain |
5 | chr11:93498600-93516600 | Weak transcription | Hela-S3 | cervix |
6 | chr11:93499200-93516600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
7 | chr11:93499800-93516600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
8 | chr11:93505800-93516600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr11:93506200-93516600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr11:93506400-93516600 | Weak transcription | Stomach Smooth Muscle | stomach |
11 | chr11:93506600-93516600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr11:93506600-93516600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
13 | chr11:93506800-93513000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
14 | chr11:93506800-93513200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr11:93506800-93516600 | Weak transcription | Brain Germinal Matrix | brain |
16 | chr11:93507600-93516600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr11:93510400-93516400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
18 | chr11:93512000-93516600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |